2022, Número S5
<< Anterior Siguiente >>
Cardiovasc Metab Sci 2022; 33 (S5)
Climaterio y menopausia
Giambruno M, Castillo G, Sosa C, Castillo-Presbot N, Zilberman J
Idioma: Inglés [English version]
Referencias bibliográficas: 10
Paginas: s502-504
Archivo PDF: 113.11 Kb.
REFERENCIAS (EN ESTE ARTÍCULO)
Maas AHEM, Rosano G, Cifkova R, Chieffo A, van Dijken D, Hamoda H et al. Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists. Eur Heart J. 2021; 42: 967-984.
Urzúa EA. Menopausia y riesgo cardiovascular. Rev Med Chile. 2016; 144: 1375-1376.
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288: 321-333.
El Khoudary SR, Aggarwal B, Beckie TM, Hodis HN, Johnson AE, Langer RD et al. Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association. Circulation. 2020; 142: e506-e532.
Sung K-T, Chandramouli C, Lo C-I, Tsai J-P, Lai Y-H, Hsia C-C et al. Association of female menopause with atrioventricular mechanics and outcomes. Front Cardiovasc Med. 2022; 9: 804336.
Soares CN, Cohen LS. The perimenopause, depressive disorders, and hormonal variability. Review article. Sao Paulo Med. J. 2001; 119: 78-83.
Afrid I. Psychological and social aspects of menopause. In: Rodriguez-Landa JF, Cueto-Escobedo J. Editors. A multidisciplinary look at menopause [Internet]. London: IntechOpen; 2017, visited August 2022.
Ramos, M B. Aspectos psicolo?gicos de la menopausia. Medicina y Salud. Universidad Autonoma de Mexico (UNAM). Docencia digital 2010. [Visitado el 22 de agosto de 2022] Disponible en: https://www.docenciadigital.unam.mx/ Disponible en: www.medicinaysalud.unam.mx/temas/2010/08_ago_2k10.pdf
Rodríguez-Guerrero NI. Terapia farmacológica en la mujer y prevención cardiovascular. Rev Colomb Cardiol. 2018; 25 (S1): 106-112.
Tadic M, Cuspidi C, Grassi G, Ivanovic B. Gender-specific therapeutic approach in arterial hypertension-challenges ahead. Pharmacol Res. 2019; 41: 181-188.